On Friday, October 26, the Centers for Medicare and Medicaid Services (CMS) announced several rule changes that affect how telehealth services will be covered under Medicare Advantage (MA) and the Medicare prescription drug program (Part D). These changes are in direct response to the Bipartisan Budget Act of 2018, which eliminated historical restrictions on telehealth reimbursement, and are intended to “improve quality of care and provide more plan choices for MA and Part D enrollees.”
Humana-Walgreens Partnership: Primary Care Focused on Medicare Advantage
Key Takeaways: Humana and Walgreens jointly announced a partnership for Human to operate...
Future Winners in Accelerating Shift to Value
Last week, CMS released its proposed rule (beware – in good government fashion it’s a whooping 607...
Taking Patient Behavior Change From Words to Deeds
The concept of behavior change, previously a footnote at best in patient engagement conversations...
Promoting Interoperability: MU Fades to Black
By Brian Murphy and Brian Eastwood Seeking to liberate the industry from its self-created morass...
What’s All the Fuss – Some Thoughts on Recent News
At times it can be challenging to draft commentary on all that is happening across this industry...
TEFCA Response Drives ONC to Reconsider
Key Takeaways: TEFCA proposed a new approach to healthcare data interoperability Industry response...
One More Step in the Long Road of Precision Medicine
CMS decision removes important barrier for some Medicare cancer patients to access next generation...
As Telehealth Tech Matures, Can Providers Catch Up?
HIMSS18 offered evidence that the telehealth market is beginning to mature, but it remains to be...